![discount label](https://static.cymitquimica.com/public/img/discount.png)
((R)-4-Hydroxy-4-methyl-orn(tritc)⁷)-phalloidincyclo(-Ala-D-Thr-Cys-cis-hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-orn(tritc))
CAS: 1926163-50-9
Ref. 3D-BCD16350
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Product Information
Fasciectomy is the surgical removal of an entire fascia. It can be used to treat a variety of conditions, including tumors and inflammation. Fasciectomy is often done in conjunction with other treatments, such as radiation therapy. This drug has been shown to decrease the growth rate of fibroblasts and induce apoptosis by targeting specific proteins. The molecular effects of this drug are dose-dependent, with higher concentrations causing more apoptosis than lower concentrations. Fasciectomy has also been shown to cause collagen loss in nodules and increased proliferation of wst-1 (a marker for cell proliferation).
Chemical properties
Technical inquiry about: 3D-BCD16350 ((R)-4-Hydroxy-4-methyl-orn(tritc)⁷)-phalloidincyclo(-Ala-D-Thr-Cys-cis-hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-orn(tritc))
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.